Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
infrastructure, with the state-of-the-art reinforcement learning and generative AI, to detect, prevent, and preemptively mitigate intelligent attacker vectors. Supportive Mentoring: The postdoc will be guided by
-
. This project is a collaboration between research institutions and Ministries of Health across Asia , building upon the existing UNITEDengue (https://www.unitedengue.org/) . You will be responsible for developing
-
Department's Website: https://engineering.uark.edu/ Summary of Job Duties: The Postdoctoral Research Associate - Biomedical Engineering will test commercially available membranes and develop novel membranes
-
(recombinant viral vectors – AAV, mouse breeding), imaging (histology, light microscopy, confocal microscopy), and strength analyses (whole body plethysmography to evaluate respiration, limb function tests
-
Vectors and Vector-Borne Diseases" team (Université Joseph Ki-Zerbo, Ouagadougou) led by Prof. Athanase Badolo for fieldwork, and with Dr. Noah Rose (University of California, San Diego) for expertise in
-
genotyping several transgenic lines with minimal to no error). As instructed, performs intracranial stereotaxic injection of viral vectors followed by locomotor behavioral analysis (this includes
-
equivalencies: https://hr.uky.edu/employment/working-uk/equivalencies Required Related Experience No experience required. Required License/Registration/Certification KY Radiation Operator’s License at time of
-
information about equivalencies: https://hr.uky.edu/employment/working-uk/equivalencies Required Related Experience No experience required. Required License/Registration/Certification KY Radiation Operator’s
-
Description The TaRGeT laboratory, led by Dr. Oumeya Adjali, focuses on the design, Chemical engineering, and in vivo evaluation of adeno-associated viral (AAV) vectors for gene therapy. We are seeking a
-
activation, cytotoxicity, and persistence. Additional methods may involve CRISPR-based perturbations, viral vector engineering, and immune cell manufacturing workflows relevant to CAR-based therapies. In vivo